Perspective Therapeutics
CATX
29 hedge funds and large institutions have $2.99M invested in Perspective Therapeutics in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.
89% more capital invested
Capital invested by funds: $1.58M → $2.99M (+$1.41M)
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
0.22% more ownership
Funds ownership: 0.63% → 0.86% (+0.22%)
3% less funds holding
Funds holding: 30 → 29 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.07M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$205K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.66K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$4.43K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.18K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$6.96K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$5K |
| 3 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
-$5K |
| 4 |
VF
Virtu Financial
New York
|
-$3.76K |
| 5 |
State Street
Boston,
Massachusetts
|
-$2.79K |
CATX Hedge Fund Activity: Q3 2018 in Review
29 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q3 2018, worth a combined $2.99M — up 89% from $1.58M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CATX and 3 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 5 added.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.07M. The largest seller was Raymond James Financial Services Advisors, cutting an estimated $6.96K.
- 29 institutional investors held Perspective Therapeutics (CATX) as of Q3 2018, down from 30 in Q2 2018.
- Funds reported $2.99M of Perspective Therapeutics stock for Q3 2018, up 89% quarter-over-quarter.
- 3 funds opened new Perspective Therapeutics positions in Q3 2018 and 4 closed out, a net change of -1 holder.
- The largest Perspective Therapeutics buyer in Q3 2018 was Sabby Management, an estimated $1.07M added.
- The largest Perspective Therapeutics seller in Q3 2018 was Raymond James Financial Services Advisors, an estimated $6.96K sold.
Based on aggregated 13F filings for Q3 2018.